[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Nuvana Healthcare LTD\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100604037","ai-driven-early-detection-of-skin-cancer-100604037",false,"NCT07144306","AI-Driven Early Detection of Skin Cancer","Skin Cancer","Inclusion Criteria:\n\nAdults (≥18 years) presenting with skin lesions suspicious for malignancy.\n\nAbility to provide informed consent.\n\nExclusion Criteria:\n\nInability to provide informed consent.\n\nPoor-quality images unsuitable for AI analysis.",true,"ALL","18 Months",{"count":20,"type":21},100,"ESTIMATED","50 Months","OBSERVATIONAL","This study evaluates the feasibility and accuracy of an AI-powered mobile platform (NuvanaDx) for early detection of skin cancer, including melanoma, using smartphone-based imaging. The platform is designed to improve access to early diagnosis, reduce waiting times, and support triage into appropriate care pathways.",[26],"Skin Cancer Melanoma",[14,28,29,30,31,32],"Melanoma","Early Detection","Artificial Intelligence","Dermatology","Digital Health","RECRUITING","2025-09-25",{"date":36,"type":37},"2025-09-26","ACTUAL",{"date":39,"type":21},"2025-10-01",{"date":41,"type":21},"2026-01-01",{"name":43,"class":44},"Nuvana Healthcare LTD","INDUSTRY",""]